Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.

[1]  S. Patiar,et al.  Oral steroids for nasal polyps. , 2016, The Cochrane database of systematic reviews.

[2]  J. Boyce,et al.  Cysteinyl leukotriene receptors, old and new; implications for asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  A. Hirano,et al.  [Aspirin-intolerant asthma]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[4]  H. Goossens,et al.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists , 2012, Rhinology journal.

[5]  M. Kim,et al.  Flow Cytometry-Assisted Basophil Activation Test as a Safe Diagnostic Tool for Aspirin/NSAID Hypersenstivity , 2012, Allergy, asthma & immunology research.

[6]  C. Bachert,et al.  Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. , 2012, The Journal of allergy and clinical immunology.

[7]  J. Mullol,et al.  Role of Medical Therapy in the Management of Nasal Polyps , 2012, Current Allergy and Asthma Reports.

[8]  J. Mullol,et al.  Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. , 2011, Rhinology.

[9]  M. Kowalski,et al.  Expression of Arachidonate Metabolism Enzymes and Receptors in Nasal Polyps of Aspirin-Hypersensitive Asthmatics , 2011, International Archives of Allergy and Immunology.

[10]  H. Korkmaz,et al.  The Prevalence of Aspirin Hypersensitivity in Patients with Nasal Polyposis and Contributing Factors , 2011, American journal of rhinology & allergy.

[11]  C. Bachert,et al.  Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. , 2011, The Journal of allergy and clinical immunology.

[12]  J Bousquet,et al.  Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study , 2011, Allergy.

[13]  J. Mullol,et al.  Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. , 2011, The Journal of allergy and clinical immunology.

[14]  C. Bachert,et al.  Diagnostic tools in Rhinology EAACI position paper , 2011, Clinical and translational allergy.

[15]  J. Mullol,et al.  Combined Oral and Intranasal Corticosteroid Therapy: An Advance in the Management of Nasal Polyposis? , 2011, Annals of Internal Medicine.

[16]  B. Rotenberg,et al.  Revision Rates after Endoscopic Sinus Surgery: A Recurrence Analysis , 2011, The Annals of otology, rhinology, and laryngology.

[17]  J. Lucas,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2009. , 2010, Vital and health statistics. Series 10, Data from the National Health Survey.

[18]  J. Mullol,et al.  Efficacy of omalizumab in the treatment of nasal polyps , 2010, Thorax.

[19]  R. Orlandi,et al.  Cost Burden of Chronic Rhinosinusitis , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[20]  C. Bachert,et al.  Oral steroids and doxycycline: two different approaches to treat nasal polyps. , 2010, The Journal of allergy and clinical immunology.

[21]  J. Lucas,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2008. , 2009, Vital and health statistics. Series 10, Data from the National Health Survey.

[22]  J. Mullol,et al.  Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. , 2009, Immunology and allergy clinics of North America.

[23]  J. Mullol,et al.  United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient’s quality of life , 2009, Allergy.

[24]  D. Stevenson.  Aspirin sensitivity and desensitization for asthma and sinusitis , 2009, Current allergy and asthma reports.

[25]  C. Bachert,et al.  Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. , 2008, The Journal of allergy and clinical immunology.

[26]  E. Meltzer,et al.  Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications , 2008, Allergy.

[27]  J. Mullol,et al.  Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient’s quality of life , 2008, Allergy.

[28]  S. Graham,et al.  Sinonasal Outcomes After Endoscopic Sinus Surgery in Asthmatic Patients With Nasal Polyps: A Difference Between Aspirin‐Tolerant and Aspirin‐Induced Asthma? , 2008, The Laryngoscope.

[29]  C. Bachert,et al.  EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity , 2007, Allergy.

[30]  G. Scadding,et al.  Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. , 2007, The Journal of laryngology and otology.

[31]  S. Kountakis,et al.  The Prevalence of Samter's Triad in Patients Undergoing Functional Endoscopic Sinus Surgery , 2007, Ear, nose, & throat journal.

[32]  S. Griest,et al.  Impact of Aspirin Intolerance on Outcomes of Sinus Surgery , 2007, The Laryngoscope.

[33]  S. Narumiya,et al.  Prostaglandin E Receptors* , 2007, Journal of Biological Chemistry.

[34]  M. Visconti,et al.  Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics. , 2006, Respiratory medicine.

[35]  O. Pfaar,et al.  Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[36]  C. Bachert,et al.  Differentiation of chronic sinus diseases by measurement of inflammatory mediators , 2006, Allergy.

[37]  K. Austen,et al.  Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthma , 2006, The Journal of pathology.

[38]  T. Zuberbier,et al.  Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. , 2006, Rhinology.

[39]  C. Picado.  Mechanisms of aspirin sensitivity , 2006, Current allergy and asthma reports.

[40]  J. Mullol,et al.  The Impact of Atopy, Sinus Opacification, and Nasal Patency on Quality of Life in Patients with Severe Nasal Polyposis , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[41]  J. Mullol,et al.  Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis , 2006, Thorax.

[42]  G. Scadding,et al.  Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. , 2006, The Journal of allergy and clinical immunology.

[43]  M. Kowalski,et al.  Aspirin‐triggered 15‐HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin‐Sensitive Patients Identification Test (ASPITest) * , 2005, Allergy.

[44]  G. Scadding,et al.  Intranasal Lysine‐Aspirin in Aspirin‐Sensitive Nasal Polyposis: A Controlled Trial , 2005, The Laryngoscope.

[45]  C. Bachert,et al.  Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. , 2005, The Journal of allergy and clinical immunology.

[46]  M. Kowalski,et al.  Association of stem cell factor expression in nasal polyp epithelial cells with aspirin sensitivity and asthma , 2005, Allergy.

[47]  W. Fokkens,et al.  Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery , 2005, The Journal of allergy and clinical immunology.

[48]  J. Mullol,et al.  Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments , 2005, Allergy.

[49]  J. Mullol,et al.  The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis , 2005, Quality of Life Research.

[50]  S. Durham,et al.  Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. , 2005, Rhinology.

[51]  J. Mullol,et al.  Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. , 2004, The Journal of allergy and clinical immunology.

[52]  R. Botting,et al.  Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition , 2004, Pharmacological Reviews.

[53]  Y. Kanaoka,et al.  Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses1 , 2004, The Journal of Immunology.

[54]  J. Mullol,et al.  Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. , 2004, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[55]  A. Higashi,et al.  Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. , 2004, The Journal of allergy and clinical immunology.

[56]  D. Ross,et al.  RANTES, eotaxin and eotaxin‐2 expression and production in patients with aspirin triad , 2003, Allergy.

[57]  P. Yarnold,et al.  Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma , 2003, The Laryngoscope.

[58]  J. Mullol,et al.  Nuclear factor‐κB activity is down‐regulated in nasal polyps from aspirin‐sensitive asthmatics , 2003, Allergy.

[59]  G. Scadding,et al.  Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. , 2002, The New England journal of medicine.

[60]  R. Simon,et al.  The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[61]  J. Mullol,et al.  Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. , 2002, The Journal of allergy and clinical immunology.

[62]  G. Scadding,et al.  An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[63]  J. Mullol,et al.  Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry , 2000, Thorax.

[64]  G. Paludetti,et al.  Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies , 2000, Thorax.

[65]  L. Ertama,et al.  Nasal polyposis: clinical course during 20 years. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[66]  C. Bachert,et al.  Nasal Polyposis: From Cytokines to Growth , 2000, American journal of rhinology.

[67]  A. Szczeklik,et al.  Natural history of aspirin‐induced asthma , 2000 .

[68]  J. Mullol,et al.  Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. , 1999, American journal of respiratory and critical care medicine.

[69]  L. Mastalerz,et al.  Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. , 1998, The Journal of allergy and clinical immunology.

[70]  J. Vane,et al.  Eicosanoids, Aspirin, and Asthma , 1998 .

[71]  R. Naclerio,et al.  Sinusitis: bench to bedside. Current findings, future directions. , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[72]  T. Schall,et al.  Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. , 1996, The Journal of allergy and clinical immunology.

[73]  P. Brandtzaeg,et al.  Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. , 1995, American journal of respiratory cell and molecular biology.

[74]  P. Abrami,et al.  Anaphylaxie et Idiosyncrasie , 1993 .

[75]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.

[76]  J. Mullol,et al.  Clinical Examinationd and Differential Diagnosis in Rhinology , 2013 .

[77]  N. Higashi,et al.  Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. , 2012, Allergology international : official journal of the Japanese Society of Allergology.

[78]  M. Kowalski,et al.  Use of Nonsteroidal Anti-Inflammatory Drugs in Patients with Aspirin Hypersensitivity , 2006, Treatments in Respiratory Medicine.

[79]  C. Vancheri,et al.  The lung as a privileged site for the beneficial actions of PGE2. , 2004, Trends in immunology.

[80]  A. Sampson.  ASPIRIN-INTOLERANT ASTHMA : NEW INSIGHTS FROM BRONCHIAL MUCOSAL BIOPSIES , 1998 .

[81]  J. Backman,et al.  Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. , 1998, Arthritis and rheumatism.

[82]  J. Montserrat,et al.  Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. , 1992, The American review of respiratory disease.

[83]  G. Settipane,et al.  Nasal polyps in asthma and rhinitis. A review of 6,037 patients. , 1977, The Journal of allergy and clinical immunology.